Onconova Therapeutics
ONTX
#10150
Rank
C$28.87 M
Marketcap
C$1.38
Share price
-0.47%
Change (1 day)
-11.65%
Change (1 year)

Earnings for Onconova Therapeutics (ONTX)

Earnings in 2024 (TTM): -C$24.36 Million

According to Onconova Therapeutics's latest financial reports the company's current earnings are C$0.22 Million. In 2023 the company made an earning of -C$26.18 Million, an increase over its 2022 earnings that were of -C$26.2 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Onconova Therapeutics from 2012 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$24.36 Million-6.97%
2023 -C$26.18 Million-0.08%
2022 -C$26.2 Million17.33%
2021 -C$22.33 Million-35.74%
2020 -C$34.75 Million17.03%
2019 -C$29.7 Million4.67%
2018 -C$28.37 Million-14.73%
2017 -C$33.27 Million22.53%
2016 -C$27.16 Million-18.14%
2015 -C$33.17 Million-62.36%
2014 -C$88.11 Million2.66%
2013 -C$85.83 Million107.68%
2012 -C$41.33 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Spectrum Pharmaceuticals
SPPI
-C$85.49 Million 240.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
C$6.09 M-124.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-C$0.38 Billion 1,387.11%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-C$95.66 Million 281.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Cleveland BioLabs
CBLI
-C$3.81 Million-84.84%๐Ÿ‡บ๐Ÿ‡ธ USA